Target intelligence / Profile preview

OPA1 antisense RNA 1 (OPA1-AS1)

Target
OPA1-AS1
Molecular classification
Long non-coding RNA, Antisense RNA, Other
01

Overview

OPA1 antisense RNA 1 (OPA1-AS1) is a long non-coding RNA that is transcribed antisense to the OPA1 gene. Antisense RNAs such as OPA1-AS1 are involved in the regulation of their corresponding sense gene (in this case, OPA1) by mechanisms including transcriptional interference, RNA-RNA interaction, and chromatin modification. While OPA1 protein plays a crucial role in mitochondrial inner membrane fusion, regulation of cristae structure, and neuronal development, OPA1-AS1 is presumed to modulate the expression level of OPA1 by natural antisense RNA mechanisms, but there is currently very limited direct functional or disease-related information specific to OPA1-AS1 in the published literature[3]. Antisense long non-coding RNAs more generally are being explored as potential therapeutic targets or biomarkers, but OPA1-AS1 itself is not currently known as a drug target, and no drugs or clinical approaches specifically modulate this molecule. No evidence currently supports OPA1-AS1 as a therapeutic target or disease biomarker; the functional and pathological roles of OPA1-AS1 specifically remain to be elucidated. If you require structured data for related protein targets, such as OPA1 itself, please specify.

Other names
OPA1-AS1OPA1 antisense RNA 1 (non-protein coding)
02

Biological functions

Regulation of gene expression at the transcriptional and post-transcriptional levelPotential involvement in chromatin remodeling and modulation of transcription for the sense OPA1 gene
03

Disease associations

Other (Specific involvement in disease largely unknown for OPA1-AS1, but OPA1 gene dysregulation is linked to neurological and mitochondrial diseases)

Beyond the preview

Go deeper on OPA1 antisense RNA 1 (OPA1-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on OPA1 antisense RNA 1 (OPA1-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call